Legal & General Group Plc grew its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 3.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 83,404 shares of the company’s stock after buying an additional 2,418 shares during the period. Legal & General Group Plc’s holdings in Nu Skin Enterprises were worth $5,115,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. NumerixS Investment Technologies Inc purchased a new stake in shares of Nu Skin Enterprises during the fourth quarter valued at approximately $108,000. Advisors Asset Management Inc. increased its stake in shares of Nu Skin Enterprises by 16.0% in the fourth quarter. Advisors Asset Management Inc. now owns 2,720 shares of the company’s stock worth $167,000 after buying an additional 375 shares during the last quarter. NINE MASTS CAPITAL Ltd increased its stake in shares of Nu Skin Enterprises by 24.0% in the fourth quarter. NINE MASTS CAPITAL Ltd now owns 3,100 shares of the company’s stock worth $190,000 after buying an additional 600 shares during the last quarter. Oppenheimer Asset Management Inc. increased its stake in shares of Nu Skin Enterprises by 19.1% in the fourth quarter. Oppenheimer Asset Management Inc. now owns 3,510 shares of the company’s stock worth $215,000 after buying an additional 562 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Nu Skin Enterprises in the third quarter worth $224,000. Institutional investors own 76.15% of the company’s stock.

Shares of NYSE:NUS opened at $50.59 on Wednesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.82 and a quick ratio of 1.15. The firm has a market capitalization of $2.82 billion, a P/E ratio of 14.37, a P/E/G ratio of 1.19 and a beta of 0.65. Nu Skin Enterprises, Inc. has a 12-month low of $44.36 and a 12-month high of $88.68.

Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Wednesday, February 13th. The company reported $1.05 earnings per share for the quarter, meeting the consensus estimate of $1.05. Nu Skin Enterprises had a net margin of 4.55% and a return on equity of 25.98%. The firm had revenue of $683.29 million during the quarter, compared to analyst estimates of $676.76 million. During the same quarter in the previous year, the firm earned $1.20 earnings per share. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. Equities research analysts predict that Nu Skin Enterprises, Inc. will post 3.9 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 13th. Shareholders of record on Monday, February 25th were paid a dividend of $0.37 per share. This is a positive change from Nu Skin Enterprises’s previous quarterly dividend of $0.37. The ex-dividend date of this dividend was Friday, February 22nd. This represents a $1.48 annualized dividend and a yield of 2.93%. Nu Skin Enterprises’s payout ratio is presently 42.05%.

A number of analysts recently issued reports on NUS shares. Zacks Investment Research upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating and set a $75.00 price target for the company in a research note on Tuesday, February 12th. ValuEngine lowered shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Wednesday, March 20th. Citigroup set a $86.00 price target on shares of Nu Skin Enterprises and gave the stock a “buy” rating in a research note on Friday, February 15th. Pivotal Research restated a “buy” rating and issued a $85.00 price target on shares of Nu Skin Enterprises in a research note on Wednesday, March 13th. Finally, Bank of America set a $65.00 price target on shares of Nu Skin Enterprises and gave the stock a “sell” rating in a research note on Friday, March 1st. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the company’s stock. Nu Skin Enterprises presently has a consensus rating of “Hold” and a consensus price target of $76.88.

ILLEGAL ACTIVITY WARNING: “Legal & General Group Plc Has $5.12 Million Stake in Nu Skin Enterprises, Inc. (NUS)” was reported by Watch List News and is the property of of Watch List News. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at https://www.watchlistnews.com/legal-general-group-plc-has-5-12-million-stake-in-nu-skin-enterprises-inc-nus/2952312.html.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Recommended Story: The benefits and drawbacks of dollar cost averaging

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.